person · Reporting owner
Bracken-Ferguson Kendra
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Longevity Health Holdings, Inc.CTCX · Entity 8659 | Chief Executive Officer | October 11, 2024 | November 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Longevity Health Holdings, Inc.
Report date October 11, 2024 · Filed November 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.36 · Expires 2034-10-11 | Direct | 378,705 |
Reported balance
After 2024-10-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-10-11 · Grant · Acquired 378,705 · Balance 378,705 F1: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.11 · Expires 2034-07-30 | Direct | 908,893 |
Reported balance
Holding disclosure · report date 2024-10-11 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 908,893 F1: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 11, 2024 Filed Nov 8, 2024 17:13 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | GrantStock Option (right to buy) · Derivative | 378,705 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950170-24-124240 · ownership.xml · derivative · entry 1 Bracken-Ferguson Kendra · CIK 0002033273 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 378,705 Underlying: Common Stock · 378,705 shares Expires 2034-10-11 F1 · derivative.exercise_date: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date. Read SEC document |
| July 30, 2024 Filed Aug 8, 2024 17:18 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | GrantStock Option (right to buy) · Derivative | 908,893 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0000950170-24-094197 · ownership.xml · derivative · entry 1 Bracken-Ferguson Kendra · CIK 0002033273 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 908,893 Underlying: Common Stock · 908,893 shares Expires 2034-07-30 F1 · derivative.exercise_date: Options to purchase 908,893 shares of common stock of Carmell Corporation were granted on July 30, 2024 and vest as follows: 25% vested on July 30, 2025 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date. F1 · derivative.underlying_shares: Options to purchase 908,893 shares of common stock of Carmell Corporation were granted on July 30, 2024 and vest as follows: 25% vested on July 30, 2025 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.